These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23939705)

  • 21. Chemokine axes in breast cancer: factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors.
    Weitzenfeld P; Kossover O; Körner C; Meshel T; Wiemann S; Seliktar D; Legler DF; Ben-Baruch A
    J Leukoc Biol; 2016 Jun; 99(6):1009-25. PubMed ID: 26936935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.
    Simiantonaki N; Jayasinghe C; Michel-Schmidt R; Peters K; Hermanns MI; Kirkpatrick CJ
    Int J Oncol; 2008 Mar; 32(3):585-92. PubMed ID: 18292935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse model.
    Kim SJ; Johnson M; Koterba K; Herynk MH; Uehara H; Gallick GE
    Clin Cancer Res; 2003 Nov; 9(14):5161-70. PubMed ID: 14613995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor hypoxia modulates podoplanin/CCL21 interactions in CCR7+ NK cell recruitment and CCR7+ tumor cell mobilization.
    Tejchman A; Lamerant-Fayel N; Jacquinet JC; Bielawska-Pohl A; Mleczko-Sanecka K; Grillon C; Chouaib S; Ugorski M; Kieda C
    Oncotarget; 2017 May; 8(19):31876-31887. PubMed ID: 28416768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis.
    Burton JB; Priceman SJ; Sung JL; Brakenhielm E; An DS; Pytowski B; Alitalo K; Wu L
    Cancer Res; 2008 Oct; 68(19):7828-37. PubMed ID: 18829538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uremia induces functional incompetence of bone marrow-derived stromal cells.
    Noh H; Yu MR; Kim HJ; Jeon JS; Kwon SH; Jin SY; Lee J; Jang J; Park JO; Ziyadeh F; Han DC; Lee HB
    Nephrol Dial Transplant; 2012 Jan; 27(1):218-25. PubMed ID: 21622994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy.
    Wang J; Seethala RR; Zhang Q; Gooding W; van Waes C; Hasegawa H; Ferris RL
    J Natl Cancer Inst; 2008 Apr; 100(7):502-12. PubMed ID: 18364504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis.
    Jennbacken K; Vallbo C; Wang W; Damber JE
    Prostate; 2005 Oct; 65(2):110-6. PubMed ID: 15880525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor A, secreted in response to transforming growth factor-β1 under hypoxic conditions, induces autocrine effects on migration of prostate cancer cells.
    Darrington E; Zhong M; Vo BH; Khan SA
    Asian J Androl; 2012 Sep; 14(5):745-51. PubMed ID: 22705563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelin-1 induces the transactivation of vascular endothelial growth factor receptor-3 and modulates cell migration and vasculogenic mimicry in melanoma cells.
    Spinella F; Caprara V; Di Castro V; Rosanò L; Cianfrocca R; Natali PG; Bagnato A
    J Mol Med (Berl); 2013 Mar; 91(3):395-405. PubMed ID: 22965194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity.
    Borghese C; Cattaruzza L; Pivetta E; Normanno N; De Luca A; Mazzucato M; Celegato M; Colombatti A; Aldinucci D
    J Cell Biochem; 2013 May; 114(5):1135-44. PubMed ID: 23192362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductal adenocarcinoma.
    Sperveslage J; Frank S; Heneweer C; Egberts J; Schniewind B; Buchholz M; Bergmann F; Giese N; Munding J; Hahn SA; Kalthoff H; Klöppel G; Sipos B
    Int J Cancer; 2012 Aug; 131(4):E371-81. PubMed ID: 22020953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matrix metalloproteinase-9 is up-regulated by CCL19/CCR7 interaction via PI3K/Akt pathway and is involved in CCL19-driven BMSCs migration.
    Zhang W; Tu G; Lv C; Long J; Cong L; Han Y
    Biochem Biophys Res Commun; 2014 Aug; 451(2):222-8. PubMed ID: 25086360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secreted factors from metastatic prostate cancer cells stimulate mesenchymal stem cell transition to a pro-tumourigenic 'activated' state that enhances prostate cancer cell migration.
    Ridge SM; Bhattacharyya D; Dervan E; Naicker SD; Burke AJ; Murphy JM; O'leary K; Greene J; Ryan AE; Sullivan FJ; Glynn SA
    Int J Cancer; 2018 May; 142(10):2056-2067. PubMed ID: 29266277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats.
    Krishnan J; Kirkin V; Steffen A; Hegen M; Weih D; Tomarev S; Wilting J; Sleeman JP
    Cancer Res; 2003 Feb; 63(3):713-22. PubMed ID: 12566318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor.
    Lin J; Lalani AS; Harding TC; Gonzalez M; Wu WW; Luan B; Tu GH; Koprivnikar K; VanRoey MJ; He Y; Alitalo K; Jooss K
    Cancer Res; 2005 Aug; 65(15):6901-9. PubMed ID: 16061674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CC-chemokine receptor 7 is overexpressed and correlates with growth and metastasis in prostate cancer.
    Chen Y; Tian Y; Ji Z; Liu Z; Shang D
    Tumour Biol; 2015 Jul; 36(7):5537-41. PubMed ID: 25682287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer.
    Zeng Y; Opeskin K; Baldwin ME; Horvath LG; Achen MG; Stacker SA; Sutherland RL; Williams ED
    Clin Cancer Res; 2004 Aug; 10(15):5137-44. PubMed ID: 15297417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis.
    Zhuo W; Jia L; Song N; Lu XA; Ding Y; Wang X; Song X; Fu Y; Luo Y
    Clin Cancer Res; 2012 Oct; 18(19):5387-98. PubMed ID: 22932666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
    Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.